PIETRANGELO, Antonello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.438
EU - Europa 10.958
AS - Asia 2.937
SA - Sud America 42
OC - Oceania 32
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 14
Totale 36.446
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.322
GB - Regno Unito 3.800
IT - Italia 2.659
SE - Svezia 1.450
CN - Cina 1.057
DE - Germania 852
UA - Ucraina 660
SG - Singapore 573
FI - Finlandia 538
HK - Hong Kong 526
TR - Turchia 374
BG - Bulgaria 286
FR - Francia 272
CA - Canada 108
IN - India 103
RU - Federazione Russa 81
ID - Indonesia 67
IE - Irlanda 59
BE - Belgio 58
MY - Malesia 50
KR - Corea 47
LT - Lituania 43
NL - Olanda 42
RO - Romania 34
IR - Iran 32
VN - Vietnam 32
JP - Giappone 28
AU - Australia 27
CH - Svizzera 26
BR - Brasile 21
ES - Italia 17
EG - Egitto 15
GR - Grecia 15
PK - Pakistan 15
CZ - Repubblica Ceca 12
EU - Europa 10
HU - Ungheria 8
CO - Colombia 7
PL - Polonia 7
PT - Portogallo 7
SA - Arabia Saudita 7
SI - Slovenia 7
AT - Austria 6
CL - Cile 6
MX - Messico 5
NZ - Nuova Zelanda 5
PH - Filippine 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AR - Argentina 4
IQ - Iraq 4
IL - Israele 3
NO - Norvegia 3
RS - Serbia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
BZ - Belize 2
EE - Estonia 2
ET - Etiopia 2
HR - Croazia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MA - Marocco 2
MC - Monaco 2
TW - Taiwan 2
VE - Venezuela 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BF - Burkina Faso 1
CM - Camerun 1
DK - Danimarca 1
EC - Ecuador 1
JO - Giordania 1
KE - Kenya 1
LU - Lussemburgo 1
ME - Montenegro 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
TH - Thailandia 1
TN - Tunisia 1
Totale 36.446
Salva come PNG Salva come JPEG
Città #
Fairfield 3.378
Southend 3.205
Woodbridge 2.261
Chandler 1.794
Houston 1.754
Ashburn 1.714
Jacksonville 1.382
Wilmington 1.134
Seattle 1.122
Cambridge 1.047
Ann Arbor 969
Dearborn 969
Nyköping 828
Hong Kong 524
Modena 497
Singapore 407
San Diego 366
Beijing 360
Helsinki 317
Chicago 310
Princeton 301
Sofia 273
Eugene 235
Izmir 201
Des Moines 153
Milan 147
Redwood City 145
New York 127
Rome 115
London 103
Los Angeles 99
Shanghai 99
Bremen 88
Bologna 87
Falls Church 77
Jakarta 59
Parma 54
Brussels 53
Ottawa 53
Philadelphia 50
Boardman 47
Norwalk 47
Dublin 44
Fremont 43
San Mateo 41
Hefei 40
Nanjing 39
Kilburn 38
Toronto 38
Florence 36
Verona 33
Bari 28
Kunming 27
Rimini 27
Dong Ket 26
Formigine 26
Reggio Emilia 26
Dallas 25
Grafing 24
Phoenix 23
Saint Petersburg 23
Jinan 21
Padova 21
Dongguan 20
Hounslow 19
Seongnam 19
Guangzhou 18
San Giuliano Milanese 18
Auburn Hills 17
Reggio Nell'emilia 17
Washington 17
Catania 16
Munich 16
Turin 16
Chiswick 15
Fuzhou 15
Genoa 15
Lappeenranta 15
Naples 14
Shenyang 14
Amsterdam 13
Nanchang 13
Prescot 13
Frattamaggiore 12
Indiana 12
Trento 12
Wuhan 12
Acton 11
Carpi 11
Kassel 11
Palermo 11
Timisoara 11
Borzano 10
Como 10
Correggio 10
Frankfurt am Main 10
Messina 10
Mumbai 10
Paris 10
Quartu Sant'Elena 10
Totale 28.103
Salva come PNG Salva come JPEG
Nome #
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 435
Association between celiac disease and idiopathic dilated cardiomyopathy: a case report. 272
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 271
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 270
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 265
Ferroportin disease: Pathogenesis, diagnosis and treatment 261
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 258
Non-HFE Hepatic Iron Overload. 257
Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene 232
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 230
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 226
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice. 226
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 217
Human macrophage ferroportin biology and the basis for the ferroportin disease 216
Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription 210
IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS? 208
An unfortunate case of post-ERCP complications 205
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 204
Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene 202
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 201
MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS. 200
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 200
BMP-6 is a Key Endogenous Regulator of Hepcidin Expression and Iron Metabolism 199
Coproporphyrin excretion in healthy newborn babies 199
ER stress controls iron metabolism through induction of hepcidin. 196
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 192
Safety and efficacy of sucrosomal iron in inflammatory bowel disease patients with iron deficiency anemia 192
Heterogeneity of hemochromatosis in Italy 191
HYPERHOMOCYSTEINEMIA AND MTHFR C677T POLYMORPHISM IN PATIENTS WITH PORTAL VEIN THROMBOSIS COMPLICATING LIVER CIRRHOSIS 189
Capitolo 31 "Malattia di Wilson ed emocromatosi", in Sezione V "Malattie del fegato" 188
Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB 188
Haptoglobin modifies the hemochromatosis phenotype in mice 187
Missed treatment in an Italian HBV infected patients cohort: HBV RER 186
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes 185
VITAMIN-E SUPPLEMENTATION PREVENTS HEPATIC CIRRHOSIS DUE TO IRON OVERLOAD IN RODENTS 184
The SMAD pathway is required for hepcidin response during endoplasmic reticulum stress 184
Activin B induces noncanonical SMAD1/5/8 signaling via BMP type I receptors in hepatocytes: Evidence for a role in hepcidin induction by inflammation in male mice 184
Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy 183
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 182
Duodenal ferritin synthesis in genetic hemochromatosis 181
Hereditary hemochromatosis--a new look at an old disease. 180
Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload 179
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 179
A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX 178
The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression 177
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 176
Liver gene expression during chronic dietary iron overload in rats 171
The impact of inherited thrombophilia on liver transplantation. 171
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 170
Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease 170
HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCCAND LIVER CIRRHOSIS 170
Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years since Hepcidin 170
Antiviral treatment profoundly affects iron status in HCV patients: Implications for management and treatment outcome 169
Reducing the risk of hospital admission: A call to action from the Italian Society of Internal Medicine 169
3-hydroxy-(4H)-benzopyran-4-ones as potential iron chelating agents in vivo 168
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 168
Iron chelation beyond transfusion iron overload 168
Altered hepatic BMP signaling pathway in human HFE hemochromatosis. 167
EASL International Concensus Conference on Hepatitis B - 13-14 September, 2002 Geneva, Switzerland Consensus Statement (Long version) 167
Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene 167
STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo 166
Primary hypoparathyroidism is common in adult patients with b-thalassemia and protect patients from osteoporosis. 166
Thyroid volume in adult beta-thalassemic patients is smaller than in controls 165
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 165
The penetrance of hemochromatosis: mice to the rescue. 164
Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion 163
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 163
Pathogens, Metabolic Adaptation, and Human Diseases--An Iron-Thrifty Genetic Model 162
Iron and steatohepatitis. 162
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 162
A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis. 161
Hepatocellular Carcinoma in HIV-infected Patients: Check Ealy, Treat Hard 160
Hemochromatosis: an endocrine liver disease. 160
Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor 158
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): A structured summary of a study protocol 158
Lipid composition and fluidity of liver plasma membranes from rats with chronic dietary iron overload. 156
BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. 156
Hepatic stellate cells are not subjected to oxidant stress during iron-induced fibrogenesis in rodents 155
DNA repair in lymphocytes from humans and rats with chronic iron overload. 155
Modulation of the synthesis of apolipoproteins in rat hepatoma cells. 155
Lack of enterocyte iron accumulation in the ferroportin disease 153
Mechanisms of iron hepatotoxicity 152
Inherited metabolic disease of the liver. 152
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 152
Ferroportin-related haemochromatosis associated with novel Y64H mutation of the SCL40A1 gene 151
Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. 149
G80S-linked ferroportin disease: The first clinical description in a Greek family 148
Luspatercept Increases Hemoglobin, Decreases Transfusion Burden and Improves Iron Overload in Adults with Beta-Thalassemia 148
Porfiria acuta intermittente: un caso "eccezionale" 148
Comorbidity does not mean clinical complexity: evidence from the RePoSI register 148
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 148
Disease progression and liver cancer in the ferroportin disease 147
Diacerhein blocks iron regulatory protein activation in inflamed human monocytes 146
Design, synthesis, and physicochemical and biological characterization of a new iron chelator of the family of hydroxychromenes 146
Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis 145
Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment 145
Huh-7: a human hemochromatotic cell line. 145
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 145
Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis 144
Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis? 144
Totale 18.258
Salva come PNG Salva come JPEG
Categoria #
all - tutte 159.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.933
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.117 0 0 271 487 781 1.035 1.243 629 727 231 389 324
2020/20216.912 524 291 526 654 830 614 775 825 271 685 496 421
2021/20225.494 284 581 517 380 223 271 393 295 619 436 861 634
2022/20235.388 612 563 348 504 647 824 114 592 645 86 244 209
2023/20243.601 169 221 511 298 529 273 301 425 133 188 192 361
2024/2025971 675 150 146 0 0 0 0 0 0 0 0 0
Totale 36.812